Focal therapy, time to join the multi-disciplinary team discussion?

ABSTRACT: Organ preserving management is common place in renal cancer, breast cancer and many other solid organ tumours. Current strategies in managing intermediate risk prostate cancer include either whole gland treatment, in the form of radical radiotherapy or radical prostatectomy, or active surveillance. The former is associated with significant post-treatment functional morbidity, whilst the latter associated with the burden of surveillance activity and patient anxiety. Focal therapy would logically fit as a middle ground for suitable patients in whom treatment would be recommended, but where much better functional outcomes may be possible. Ideally this comes without restricting the successful prevention of harm from the cancer. Historically limitations in developing tissue preserving focal the

SUBMITTER: Reddy D 

PROVIDER: S-EPMC7354327 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature